Connect with us

Hi, what are you looking for?

High Times
0

Health

Dozens of Legal, Now Banned, Drugs Received More Approvals from the FDA than Pot Could Ever Hope For

Adderall and Weed: Learn More About the Combo
Getty Images

Although authoritative researchers have been reporting on the medical benefits of cannabis on a regular basis, the DEA continues to classify it as a Schedule I drug.

Meanwhile, the Food and Drug Administration (FDA) churns out approval after approval for numerous prescription drugs, which are later pulled from the market for a variety of reasons. Those reasons can range from their lack of ability to cure anyone to their distinct ability to harm or kill someone.

While cannabis—known not to kill or maim anyone but rather to do just the opposite—has not had the courtesy of even an invitation to be considered for review.

In a true case of Catch-22, prohibitionists will often cite inadequate research as a reason for opposing legalization.

But with the exception of a few instances, major obstacles continue to block cannabis research here in the United States.

Recently, for example, Attorney General Jeff Sessions effectively shut down the DEA’s new research program.

Meanwhile, according to ProCon.org, the FDA has recalled 35 prescription drugs from the U.S. market since the 1970s.

The FDA, per ProCon.org, says that a “drug is removed from the market when its risks outweigh its benefits. A drug is usually taken off the market because of safety issues with the drug that cannot be corrected, such as when it is discovered that the drug can cause serious side effects that were not known at the time of approval.”

If negative side effects were not known at the time of approval, doesn’t this beg the question: Why? Apparently, these prescription drugs were not properly researched, yet they hit the market, did their damage, then were quietly removed from the shelves.

Welcome to the vicious cycle.

If you’re feeling ambitious, check out ProCons list of 35 drugs that have been removed from the market.

Then, if you’re still feeling ambitious, call, write or visit your Congress person and ask her/him the same question posed above: Why?

Why isn’t cannabis re-scheduled, researched and open for FDA approval—just like all the rest of them?

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

HT Newsletter

Subscribe for exclusive access to deals, free giveaways and more!

Thank you for subscribing.

Something went wrong.

Advertisement

You May Also Like

News

A cannabis lobbying group is asking the DEA to leave cannabis research to health experts.

Español

as regulaciones federales limitan el alcance que podría tener probar con marihuana en pacientes, a diferencia de los rigurosos estándares de prueba para otros...

News

The move will make it easier for patients and caretakers to access the medication.

News

The DEA seems to be advancing plans to expand medical marijuana research.

Science

Research Director Ziva Cooper will use the funds to research terpenes and pain management.

News

The real high level drug dealers are finally being held accountable.

News

New spending package initiates key changes to tobacco laws.

Culture

From the October, 1980 edition of High Times comes a portrait of a controversial pill that defined an era.

Do NOT follow this link or you will be banned from the site!